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Abstract: Introduction: The Epworth Sleepiness Scale (ESS) is often used in the evaluation of obstructive sleep apnea 
(OSA), though questions remain about the influence gender, ethnicity, and body morphometry have in the responses to 
this questionnaire. The aim of this study was to examine differences in ESS scores between various demographic groups 
of patients referred for polysomnography, and the relationship of these score to sleep-disordered breathing 
Methods: Nineteen hundred consecutive patients referred for polysomnographic diagnosis of OSA completed 
questionnaires, including demographic data and ESS. OSA was determined based on a respiratory disturbance index 
(RDI) 15 by polysomnography. 
Results: In this high risk population for OSA, the ESS was 10.7 ± 5.6. The highest ESS scores were seen in obese males; 
non-obese females and non-obese Caucasian males scored the lowest. ESS was weakly correlated with RDI (r = 0.17, P < 
0.0001). The sensitivity of ESS for the diagnosis of OSA was 54% and the specificity was 57%. The positive (PPV) and 
negative (NPV) predictive values were 64% and 47%, respectively. In obese subjects, the sensitivity and specificity were 
55% and 53%, compared with 47% and 63% in non-obese subjects. In obese, Hispanic males, the sensitivity, specificity, 
and PPV were 59%, 54%, and 84%, respectively. In non-obese, Caucasian females, the sensitivity, specificity, and NPV 
were 43%, 59%, and 72%. 
Conclusions: The ESS appears to be affected by many factors, including gender, ethnicity, and body morphometry. The 
ability of the ESS to predict OSA is modest, despite a significant correlation with the severity of OSA. The test 
characteristics improve significantly when applied to select populations, especially those at risk for OSA. 
Keywords: Ethnicity, gender, obstructive sleep apnea, epworth sleepiness scale, screening. 
INTRODUCTION 
Background 
  Obstructive sleep apnea (OSA) is a common medical 
disorder with general health and quality-of-life implications 
[1]. Associations with important medical conditions, 
including diabetes mellitus, coronary arterial disease, 
congestive heart failure, hypertension, and cerebrovascular 
accident, are well-documented, especially in moderate-to-
severe OSA [1-6]. Untreated OSA may result in excessive 
daytime sleepiness, impaired decision-making and auto- 
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mobile accidents [7-9]. Continuous overnight polysomno-
graphy (PSG) performed in a sleep laboratory remains the 
current gold standard for diagnosis of OSA. Screening 
strategies for use in the primary care setting have been 
developed, with the goal of detecting patients at risk for 
OSA, and subsequent referral for PSG. 
  One such commonly used screening strategy is the 
Epworth Sleepiness Scale (ESS). This questionnaire relies on 
self-reported patient symptoms, asking “How likely are you 
to doze off or fall asleep?” in a set of 8 hypothetical 
situations, each scored 0-3, giving a total score 0-24. This 
test has provided mixed results in the detection of OSA. The 
scale effectively discriminated between primary snoring and 
OSA in early studies [10, 11]. An ESS score of 10 is most 
often considered to be the upper limit of normal, though 
more recent work has shown that a lower score (8) may be 
associated with abnormal daytime sleepiness [12, 13]. 
  While primarily designed and developed as a measure of 
excessive daytime sleepiness, the ESS emerged as an Clinical Implications of the Epworth Sleepiness Scale  The Open Respiratory Medicine Journal, 2012, Volume 6    21 
important clinical tool in the workup and management of 
OSA. Some studies have relied on the use of the ESS to 
screen patients for sleep apnea and clinically this remains the 
most widespread tool for primary care physicians to triage 
patients for sleep evaluations [14]. Not only is it part of the 
screening process in determining referrals to sleep labs for 
PSG, but it remains part of the clinical decision-making 
process in determining who should get treatment, especially 
in cases of mild OSA [15]. The predictive properties of this 
instrument in the high-risk population of patients referred to 
the sleep laboratory for a sleep study for evaluation of 
clinically suspected OSA are not well established. Moreover, 
the impact of OSA on individual patients is partially affected 
by their demographic characteristics, i.e. gender and 
ethnicity [16 -18]; body mass index may affect how OSA 
will impact a patient. The ESS is also subject to variations in 
self-reported symptoms by these same populations. It has 
been reported that African American subjects reported higher 
ESS scores than Caucasians, while gender and age did not 
influence the average score, in a study of insomnia [19]. 
Other studies have reported that being Maori in New 
Zealand is independently associated with elevated ESS score 
[20]. An analysis of normal patients in the Sleep Heart 
Health Study showed no association of age, sex, or BMI on 
the ESS [21], however ESS scores varied despite similar 
rates of subjective sleepiness [22]. Thus, it is likely that the 
ESS, which assesses only daytime sleepiness, may vary 
among different demographic groups; its relationship with 
OSA may also vary between these same groups. 
  This retrospective study was designed to examine the 
differences in ESS scores between demographic groups (and 
subgroups) of a cohort of patients referred for PSG. Because 
the ESS is commonly used to screen patients for OSA, we 
sought to determine if the predictive value of the ESS for 
OSA varies between these same groups and subgroups. 
MATERIALS AND METHODOLOGY 
Study Participants 
  Data were collected from 2112 consecutive eligible 
patients referred to the Torr Sleep Center (Corpus Christi, 
TX) for PSG evaluation of suspected OSA between February 
5, 2007 and June 26, 2009. All subjects were 12 years of 
age without a prior diagnosis of OSA. Subjects were 
excluded from the final analysis if the ESS was incomplete 
or if they failed to undergo PSG and recording of the 
respiratory disturbance index (RDI). The protocol was 
approved by the CHRISTUS Spohn Hospital Corpus Christi 
Institutional Review Board (#08 08013). 
Baseline Evaluation 
  Prior to undergoing PSG, the subjects completed 
questionnaires. A general health questionnaire obtained 
information about demographics and general sleep health, 
including objective daytime sleepiness, as measured by the 
Epworth Sleepiness Scale [10]. Gender and ethnicity were 
self-reported by the participants. Physical examination was 
performed by trained technologists. The general examination 
included height and weight measurement. 
 
 
Polysomnographic Evaluation 
  Overnight comprehensive PSG was performed in the sleep 
laboratory, with multichannel recordings monitoring 
electroencephalogram, electrocardiogram, electrooculograms, 
submentalis electromyogram, airflow, respiratory effort, oxygen 
saturation, and anterior tibialis electromyogram. Data were 
scored by a technologist manually, according to the American 
Academy of Sleep Medicine Scoring Guidelines [23]. An apnea 
was scored if there was cessation of airflow for 10 seconds; a 
hypopnea was scored if there was 30% reduction in airflow for 
10 seconds, associated with a drop in SaO2 4%; a respiratory 
effort related arousal (RERA) was scored if there was a 
sequence of breaths, not qualifying as apnea or hypopnea, 
lasting  10 seconds with increasing respiratory effort or 
flattening of the nasal pressure waveform leading to an arousal 
from sleep. The RDI was calculated by summing the number of 
obstructive apneas, hypopneas, and RERAs per hour. 
Technologists were chosen with minimum experience of 
scoring 500 PSG, and intra- and inter-scorer variability were 
standardized by means of a point system in place at the sleep 
center [24]. 
Statistics 
  Comparisons between the means of 2 normally 
distributed groups were performed with the unpaired t-test, 
between 2 non-normally distributed groups with the Mann-
Whitney U test, and between 3 or more non-normally 
distributing groups with the Kruskal-Wallis test. Sensitivity 
and specificity of the ESS in the detection of OSA were 
calculated based using ESS 10 as a positive test result and 
RDI  15 events/hour as the diagnostic standard for OSA. 
Correlation analysis was performed by calculating the 
Spearman rank correlation coefficient for nonparametric 
samples. A p-value of <0.05 was considered statistically 
significant. 
RESULTS 
Clinical Characteristics and Demographics 
  A total of 2112 patient records were evaluated for 
inclusion into the study, of which 1900 had complete data 
collected and were included in the final analysis. Of the 
excluded patients, the vast majority were because of missing 
ESS questionnaires. Excluded patients did not differ 
significantly from those included in terms of age, height, 
body mass index (BMI), RDI, or lowest O2 saturation during 
the PSG; the excluded patients did have a higher mean 
weight than included patients (71 vs 68 kg, p=0.047) and 
were more likely to be male (65% vs 58%. P=0.037). The 
baseline clinical characteristics and demographics of the 
included participants, separated by gender are shown in 
Table 1. In general, men were larger by height and weight, 
though the average body mass index (BMI) was higher in 
females. Indices of OSA, such as RDI and lowest SaO2 were 
more severe in males, and the mean ESS was higher in males 
(11 vs 10). The subjects predominantly identified themselves 
as Hispanic or Caucasian in both groups, and the mean BMI 
fell within the range of obesity; subject characteristics were  
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otherwise unremarkable. Three subjects (all Caucasian) did 
not report their gender on the pre-PSG questionnaires. Table 
2 shows the demographic and clinical characteristics 
separated by race. 
Epworth Sleepiness Scale Scores Differ by Demographic 
and Clinical Characteristics 
  The mean ± s.d. ESS score for all patients was 10.7 ± 5.6. 
The distributions of ESS within each of the major groups 
evaluated (separated by gender, ethnicity, and obesity status) 
and subgroups (combinations of demographic and clinical 
factors such that only one subgroup is appropriate for each 
patient) are shown in Fig. (1A, B), respectively. ESS scores 
varied significantly by group and subgroup (P<0.0001 by 1-
way ANOVA for both sets). Within the major groups, the 
non-obese patients had significantly lower ESS scores than 
obese patients and the cohort as a whole. Males reported 
significantly higher ESS scores than females. The highest 
scores were noted in males (11.1 ± 5.7), Hispanics (11.1 ± 
6.0), and obese patients (11.1 ± 5.6). The only group with a 
mean score <10 was non-obese patients (9.7 ± 5.5). 
  Only subgroups involving either Caucasian or Hispanic 
patients were analyzed, because a) the “other ethnicities” 
group was too small to effectively subdivide and b) clinically 
Table 1.  Demographic and Clinical Characteristics of the Participants 
 
Group Males  Females  P-Value 
Number  1092 805   
Age, years (± s.d.)  53 ± 15  55 ± 14  0.0020 
Height, cm (± s.d.)  177 ± 8  161 ± 9  <0.0001 
Weight, kg (± s.d.)  73 ± 18  63 ± 17  <0.0001 
Body mass index, kg/m
2 (± s.d.)  35 ± 8  36 ± 9  0.0003 
Neck circumference, cm (± s.d.)  17 ± 2  15 ± 3  <0.0001 
Ethnicity, no. (%)     
Caucasian  593 (54%)  401 (50%)  ns 
Hispanic  471 (43%)  385 (48%)  0.045 
Other
†  28 (3%)  18 (2%)  ns 
TST, minutes (± s.d.)  343 ± 79  346 ± 76  ns 
Sleep efficiency, % (± s.d.)  77 ± 16  78 ± 17  ns 
RDI, events/hour (± s.d.)  37 ± 30  23 ± 27  <0.0001 
Lowest SaO2, % (± s.d.)  77 ± 12  81 ± 10  <0.0001 
*s.d. = standard deviation; cm = centimeters; kg = kilograms; m = meters; no. = number; ESS = Epworth Sleepiness Scale score; AHI = apnea-hypopnea index, SaO2 = 
oxyhemoglobin percentage, ns = not significant. 
†Other reported ethnicities: Black (n = 36), Asian (n = 4), American Indian (n = 2), Filipino (n = 1), Indian (n = 1), Lebanese (n = 1), and Portuguese (n = 1). 
 
Table 2.  Demographic and Clinical Characteristics of the Participants by Ethnicity 
 
Group Caucasian  Hispanic  Other  P-Value 
Number  998 856  46   
Age, years (± s.d.)  56 ± 14  52 ± 14  52 ± 16  <0.0001 
Height, cm (± s.d.)  173 ± 10  166 ± 11  174 ± 11  <0.0001 
Weight, kg (± s.d.)  68 ± 17  69 ± 18  75 ± 22  ns 
Body mass index, kg/m
2 (± s.d.)  34 ± 8  37 ± 9  37 ± 11  <0.0001 
Neck circumference, cm (± s.d.)  16 ± 3  17 ± 3  17 ± 2  ns 
Male, no. (%)
†  593 (60%)  471 (55%)  28 (61%)  ns 
TST, minutes (± s.d.)  340 ± 78  348 ± 79  346 ± 66  ns 
Sleep efficiency, % (± s.d.)  77 ± 16  79 ± 17  78 ± 13  0.015 
RDI, events/hour (± s.d.)  27 ± 27  36 ± 31  30 ± 30  <0.0001 
Lowest SaO2, % (± s.d.)  80 ± 10  77 ± 12  77 ± 15  0.0001 
*s.d. = standard deviation; cm = centimeters; kg = kilograms; m = meters; no. = number; ESS = Epworth Sleepiness Scale score; AHI = apnea-hypopnea index;   
SaO2 = oxyhemoglobin percentage; ns = not significant. 
†Gender was not reported by 3 participants (all Caucasian). Clinical Implications of the Epworth Sleepiness Scale  The Open Respiratory Medicine Journal, 2012, Volume 6    23 
important conclusions could not be drawn from such 
heterogeneous subgroups. Most of the subgroups showed 
similar ESS scores to other subgroups that differed by a 
single factor (i.e., obese Caucasian males were similar to 
obese Caucasian females); the exception was obese 
Caucasian males who reported higher ESS scores than non-
obese Caucasian males. Otherwise, obese Hispanic males 
scored higher than non-obese Caucasian males, obese 
Caucasian females, non-obese Caucasian females, and non-
obese Hispanic females. The highest ESS scores were from 
obese Hispanic males (12.0 ± 6.0) and obese Caucasian 
males (11.2 ± 5.4). Non-obese Caucasian males (9.5 ± 5.1), 
non-obese Caucasian females (9.5 ± 5.2), non-obese 
Hispanic females (9.5 ± 5.8), and obese Caucasian females 
(9.97 ± 5.08) scored the lowest. 
Relationship of the Epworth Sleepiness Scale Score to 
Obstructive Sleep Apnea 
  In the overall cohort of patients, those with OSA (RDI 
15) had significantly higher ESS scores than those without 
OSA (P<0.0001). The mean ± s.d. ESS scores are shown in 
Table 3 for patients with and without OSA in the groups and 
subgroups mentioned above. The major groups for which the 
ESS was significantly higher in those with OSA included 
males, Caucasians, Hispanics, obese, and non-obese patients. 
For subgroups, the same held true for obese Caucasian 
males, obese Hispanic males, and non-obese Hispanic males. 
In non-obese Caucasian females, the ESS was actually 
higher in patients without OSA, though not significantly. 
The 90
th percentile ESS scores for patients without OSA was 
calculated for each group, as this would serve as a potential  
 
upper limit of normal (ULN) when the ESS is applied as a 
screening tool for OSA. Each group produced a calculated 
ULN too high to be clinically useful for detection of OSA. 
The 10
th percentile of ESS in patients with OSA (i.e., lower 
limit of abnormal) was consistently in the 3-4 range for all 
groups and subgroups. 
  The correlations of between ESS and indices of OSA 
severity (RDI and lowest SaO2) also varied between groups. 
The correlations for the overall study group, as well as each 
group and subgroup are listed in Table 4. In the overall study 
cohort, the ESS correlated significantly with RDI (r = 0.17, 
P<0.0001) and lowest SaO2 (r = -0.20, P<0.0001). Of the 
groups that demonstrated a significant correlation between 
ESS and the markers of OSA, that association was almost 
universally stronger with the lowest SaO2 than with RDI, 
though if there was a significant correlation with one of the 
markers, there was most likely also a significant correlation 
with the other within the same group. The correlation 
between ESS and RDI was most pronounced in males (r = 
0.21), Hispanics (r = 0.19), and those that had OSA on the 
PSG (r = 0.20); significant correlations were seen with 
lowest SaO2 were in the overall group (r = -0.20), males (r = 
-0.22), Caucasians (r = -0.22), Hispanics (r = -0.24), obese (r 
= -0.20), and those with OSA (r = -0.25). In the subgroups, 
consistently significant associations between the ESS and 
severity of OSA were seen in obese Caucasian males (r = 
0.21 for RDI; r = -0.21 for lowest SaO2), obese Hispanic 
males (r = 0.18 for RDI; r = -0.22 for lowest SaO2), and non-
obese Hispanic males (r = 0.29 for RDI; r = -0.27 for lowest 
SaO2). 
 
 
 
Fig. (1). Epworth Sleepiness Scale (ESS) scores of patients referred for polysomnography. (A) Box (25-75 percentile) and whisker (10-
90 percentile) plots are shown depicting the ESS scores of All (N = 1900), Male (N = 1092), Female (N = 805), Caucasian (N = 998), 
Hispanic (856), Other ethnicities (Other, N = 46), Obese (N = 1370), and Non-obese (N = 529) patients. (B) Box and whisker plots are 
shown for subgroups of patients: obese Caucasian males (OCM, N = 397), non-obese Caucasian males (NCM, N = 198), obese Hispanic 
males (OHM, N = 364), non-obese Hispanic males (NHM, N = 104), obese Caucasian females (OCF, N = 269), non-obese Caucasian 
females (NCF, N = 130), obese Hispanic females (OHF, N = 303), and non-obese Hispanic females (NHF, N = 82). # Non-obese patients 
differed significantly in ESS scores than all patients. * ESS scores differed significantly between males and females, and between obese and 
non-obese patients. ** ESS scores differed significantly between obese and non-obese Caucasian males. 24    The Open Respiratory Medicine Journal, 2012, Volume 6  Hesselbacher et al. 
 
Performance of the Epworth Sleepiness Scale in 
Screening for Obstructive Sleep Apnea 
  In all participants, the sensitivity of ESS for predicting OSA 
was 54% and specificity was 57%. The positive predictive value 
(PPV) was 64% and negative predictive value (NPV) was 47. In 
males, the sensitivity was 56%, specificity was 58%, PPV was 
74%, and NPV was 38%; in females, sensitivity was 49%, 
specificity was 56%, PPV was 48%, and NPV was 57%. 
Among the self-reported ethnicity groups, the ESS displayed the 
best sensitivity in Hispanics (56%) and best specificity in 
Caucasians (57%). The PPV was substantially better in 
Hispanics (69%) than either Caucasian (59%) or other races 
(50%), while the NPV was <50% for all 3 ethnicity groups. In 
obese subjects, sensitivity was 55%, specificity was 53%, PPV 
was 68%, and NPV was 40%, compared with sensitivity of 
47%, specificity of 63%, PPV of 49%, and NPV of 61% for 
non-obese subjects. Sensitivities and specificities for each group 
are shown in Fig. (2A). 
    The sensitivities and specificities in clinical and 
demographic subgroups are shown in Fig. (2B). The highest 
sensitivity was seen in obese Hispanic males (59%); the 
corresponding specificity was 54%. The highest specificity 
was seen in non-obese Hispanic males (76%), which also 
had a sensitivity of 55%, making this subgroup the one in 
which the ESS is most accurate in predicting OSA. As 
above, sensitivity and specificity analyses were not 
performed for males or females of other ethnicities due to 
small group sizes. Calculations of the test characteristics 
were repeated using other ESS ULN to determine if what 
ULN would result in a sensitivity >90% in each subgroup. 
These results were similar to those from the overall group: in 
each group, only an ESS ULN in the 3-4 range resulted in 
sufficient sensitivity to serve as a screening test, though also 
provided very poor specificity (7-22%). 
DISCUSSION 
  In this cohort of patients referred for PSG evaluation of 
suspected OSA, we found that ESS scores differed by 
ethnicity, gender, and body morphometry. The ESS was 
highest in obese males (Hispanic and Caucasian); scores 
were lowest in non-obese females and non-obese Caucasian 
males. Some of these differences can be explained by the 
presence or absence of OSA; there were weak, but 
statistically significant correlations between ESS score and 
PSG indices of OSA severity (RDI and lowest SaO2). 
However, the enormous overlap of ESS scores between 
those that have OSA and those that don’t suggests additional 
unmeasured factors influencing ESS score. 
  It is unclear from these data why an obese male and non-
obese female with similar severities of OSA may report 
different degrees of sleepiness using the ESS. Reported 
symptoms of sleep-disordered breathing are known to vary 
across ethnicities and genders [25, 26]. This is likely to have 
a strong influence on PSG referral patterns from primary 
care. Any cultural or language barriers that inhibit medical 
history-taking could also influence the likelihood of referral. 
This is an important factor in interpretation of our data, since 
our cohort was comprised of patients referred for PSG. 
Comparison with the at-large community may help elucidate 
factors behind these findings. 
  Demographic and clinical characteristics help stratify risk 
for a range of sleep disorders, not limited to OSA, many of 
Table 3.  Epworth Sleepiness Scale (ESS) Scores in Groups of Patients Referred for Polysomnography 
 
Group  No OSA (Mean ± s.d.)  OSA (Mean ± s.d.)  P-Value  90
th pct for No OSA 
All participants  9.8 ± 5.4  11.3 ± 5.7  <0.0001  17 
Male  9.8 ± 5.5  11.7 ± 5.7  <0.0001  18 
Female  9.8 ± 5.3  10.6 ± 5.5  ns  17 
Caucasian  9.8 ± 5.2  10.7 ± 5.2  0.004  17 
Hispanic  9.8 ± 5.6  11.9 ± 6.1  <0.0001  17 
Other Ethnicities  10.0 ± 5.7  11.5 ± 4.8  ns  16 
Obese  10.2 ± 5.3  11.6 ± 5.7  <0.0001  17 
Non-obese  9.2 ± 5.4  10.3 ± 5.4  0.015  17 
Subgroups 
Obese Caucasian Males  10.4 ± 5.5  11.5 ± 5.3  0.044  18 
Non-obese Caucasian Males  9.1 ± 5.2  10.0 ± 5.0  ns  18 
Obese Hispanic Males  10.3 ± 5.7  12.4 ± 6.1  0.018  18 
Non-obese Hispanic Males  8.3 ± 5.5  11.7 ± 6.3  0.005  18 
Obese Caucasian Females  9.8 ± 4.9  10.1 ± 5.3  ns  16 
Non-obese Caucasian Females  9.7 ± 5.2  9.2 ± 4.5  ns  17 
Obese Hispanic Females  10.2 ± 5.5  11.3 ± 6.1  ns  17 
Non-obese Hispanic Females  9.2 ± 5.8  10.3 ± 6.0  ns  17 
*s.d. = standard deviation; OSA = obstructive sleep apnea (respiratory disturbance index  15 events/hour); pct = percentile; ns = not significant. Clinical Implications of the Epworth Sleepiness Scale  The Open Respiratory Medicine Journal, 2012, Volume 6    25 
which may result in the symptom of sleepiness. The most 
obvious example of this in our study is obesity, which is a 
known predisposing factor for OSA. Other, more subtle, 
factors are also likely to play a role. Females, especially pre-
menopausal women, are at a somewhat reduced risk of OSA 
compared with males; therefore the likelihood that another 
sleep disorder is causing the increased sleepiness is relatively 
higher. The role of ethnicity in the risk of OSA is less clear 
and bears further study. One study has shown that African 
American patients with OSA often present younger and with 
more severe disease [27]. While this is not likely to affect 
our results due to the small proportion of African American 
participants, the Hispanic group in our current study was also 
younger and had higher overall RDI than the Caucasian 
group. Another factor that must be considered is the 
possibility that an RDI 15 holds different meanings for 
different populations. For example, while the Sleep Heart 
Health Study demonstrated increased risk of cardiovascular 
diseases and mortality in men with moderate-to-severe OSA, 
the same relationships did not always hold up in women [1, 
2, 4]. Current categorization of OSA is the same across all 
adult populations as large, population-based studies, 
generating normative data based on ethnicity and gender are 
lacking to this point. 
  The ESS performed modestly overall in predicting 
significant OSA in our cohort. The test characteristics varied 
based on the population to which it was applied. Overall, the 
ESS demonstrated the highest sensitivity for OSA in obese 
males of all ethnicities, and the specificity was highest in 
non-obese Caucasian and Hispanic males. In all analyses, the 
test performed best in non-obese Hispanic men. When 
applied to women, especially non-obese women, the 
sensitivity suffered. Thus, while the ESS can be a useful tool 
for the evaluation of OSA, the results must be taken in 
context of the overall clinical picture; the clinical and 
demographic attributes of the patient can be somewhat 
helpful in interpreting the ESS. 
  When comparing the present study with an earlier study 
evaluating the utility of ESS in patients with OSA [11], there 
are some significant differences in the results. The prior 
study reported significant correlations between the ESS and 
Table 4.  Correlation Coefficients of the Epworth Sleepiness Scale with Severity of Sleep-Disordered Breathing in Groups and 
Subgroups of the Study Population 
 
Group  Correlation with RDI  Correlation with Lowest SaO2 
Overall  0.17** -0.20** 
Males  0.21** -0.22** 
Females  0.09* -0.14** 
Caucasian  0.14** -0.22** 
Hispanic  0.19** -0.24** 
Other ethnicities  0.15 -0.16 
Obese  0.17** -0.20** 
Non-obese  0.10* -0.09 
OSA  0.20** -0.25** 
No OSA  0.01 -0.01 
     
Subgroup combinations    
Obese Caucasian males  0.21**  -0.21** 
Non-obese Caucasian males  0.07  -0.08 
Obese Hispanic males  0.18**  -0.22** 
Non-obese Hispanic males  0.29**  -0.27** 
Obese males – other ethnicities  0.14  -0.19 
Non-obese males – other ethnicities  -0.36  -0.05 
Obese Caucasian females  0.03  -0.04 
Non-obese Caucasian females  0.03  -0.03 
Obese Hispanic females  0.10  -0.21* 
Non-obese Hispanic females  0.08  -0.03 
Obese females – other ethnicities  0.22  -0.02 
Non-obese females – other ethnicities  0.80  -0.80 
* P < 0.05. 
** P < 0.001. 
RDI = respiratory disturbance index; SaO2 = oxyhempglobin percentage; OSA = obstructive sleep apnea (RDI 15). 26    The Open Respiratory Medicine Journal, 2012, Volume 6  Hesselbacher et al. 
both RDI (r = 0.44) and minimum SaO2 (r = -0.40). In the 
current study, while the ESS is significantly correlated with 
both PSG measures of OSA, the correlations are not nearly 
as strong. Some technical details of the analysis may 
contribute to this discrepancy. The scoring criteria have 
changed substantially since 1993; therefore while RDI 
represents similar results in both studies, the absolute and 
relative values may be markedly different. Most likely, the 
divergent results are due to dissimilar study populations. 
Though both studies made use of patients referred to a sleep 
lab for suspicion of OSA, 40% of the subjects in the previous 
study did not have any significant OSA (RDI <5), compared 
with 17% in the current study. In addition, the present study 
population tended to be older and more obese than the earlier 
study group. It is unclear if gender or ethnic differences play 
a role in the discrepancies. 
  A more recent study has re-evaluated ESS cutoff points 
for the identification of OSA [13]. That study used a 
receiver-operator curve (ROC) to evaluate the study 
performance, finding an area under ROC = 0.60 for detection 
of AHI  5 and the optimal cutoff score was ESS >8. The 
calculated sensitivity in our present study is lower than 
reported in that study, even when using RDI 5 and ESS >8 
as cutoff values (76% in the previous study vs 63% now). 
This again may be due to a change in respiratory event 
scoring (scoring rules changed in the interim), as the 
previously reported specificity was 31% compared with 44% 
in our data set. A reduction in sensitivity, combined with 
increase in specificity, suggests a consistent shift in the data; 
a similar result is seen when moving the ESS cutoff to 6 in 
our data, but keep the RDI 15 cutoff (sensitivity = 75%; 
specificity = 31%). Because of these differences in scoring 
techniques or other reasons, our data do not support the use 
of either ESS > 10 or ESS > 8 alone as screening tools for 
OSA, given the low sensitivity. 
  A limitation of the present study that may hinder 
generalization of the results is the population under 
investigation. The study was performed at a single sleep 
center, which maintains consistency in scoring and 
implementation of the tests, but the population in this area is 
heavily skewed toward Caucasians and Hispanics. Given 
such few participants from other ethnicities, few if any, 
conclusions should be drawn about those subgroups. 
Additionally, our population had a high prevalence of OSA. 
The cutoff of RDI 15 was chosen in part to minimize bias 
introduced by the high prevalence of OSA in the population, 
which can alter the PPV and NPV results, but may also 
impact the sensitivity and specificity calculations. The 
results were similar when we analyzed our data using an RDI 
5 as the cutoff for OSA. 
  Another major limitation is that all patients were referred 
to the sleep center for a sleep test and thus the results may 
not be generalizable to a more heterogeneous primary care 
practice which includes patients with varied symptom and 
clinical profiles. At the same time, the ESS marks the single 
most commonly used modality to trigger a decision point 
with regards to referral for a sleep evaluation. It is our view 
that a more realistic appraisal of the predictive characteristics 
of this measure will enable primary care physicians and 
other specialty physicians, who are trying to ascertain sleep 
apnea risk in their heterogeneous population, to avoid a 
exclusive reliance on this one metric in influencing their 
referral decisions. We suspect that the modest associations 
seen in a population that was referred to a sleep center will 
only be rendered less specific in a more heterogeneous 
population which may include patients with varied other that 
may be associated with excessive daytime sleepiness   
  While our study analyzed the effects of gender, ethnicity, 
and obesity on the ability of the ESS to detect OSA, other 
clinical and demographic characteristics should also be 
considered for analysis. Chief among the potential candidates 
are age and mood disorders. A study reported that these affect 
self-reported daytime sleepiness independently of sleep apnea 
[28], these also may alter the way in which sleep-disordered 
 
Fig. (2). Test characteristics of the Epworth Sleepiness Scale (ESS) in the diagnosis of obstructive sleep apnea (OSA), related to 
gender, ethnicity, and body mass index. (A) The sensitivity and specificity of the ESS for the diagnosis of OSA are plotted for the overall 
study population (N = 1900), males (N = 1092), females (N = 805), Caucasians (N = 998), Hispanics (N = 856), other races (N = 46), obese 
(N = 1370), and non-obese (N = 529). (B) The sensitivity and specificity of the ESS for the diagnosis of OSA are plotted for obese Caucasian 
males (OCM, N = 397), non-obese Caucasian males (NCM, N = 198), obese Hispanic males (OHM, N = 364), non-obese Hispanic males 
(NHM, N = 104), obese Caucasian females (OCF, N = 269), non-obese Caucasian females (NCF, N = 130), obese Hispanic females (OHF, N 
= 303), and non-obese Hispanic females (NHF, N = 82). Clinical Implications of the Epworth Sleepiness Scale  The Open Respiratory Medicine Journal, 2012, Volume 6    27 
breathing is perceived by the patient. Data on the effects of age 
on self-reported daytime sleepiness have been inconsistent [19-
21]. If the proper clinical characteristics can be identified, 
normative data for the ESS could then be determined for those 
subgroups, optimizing its utility as a screening tool for OSA. 
CONCLUSIONS 
  While the ESS is well-validated to detect sleepiness, 
including patients with OSA, it is probably influenced by other 
factors, including gender, ethnicity, and body morphometry. Its 
sensitivity to detect clinically important OSA is insufficient to 
be used as a screening tool in the absence of other clinical data. 
Therefore, patients in whom there is clinical suspicion for OSA 
should undergo diagnostic testing, even in cases with normal 
ESS scores. The test characteristics of the ESS improve 
significantly when applied to select populations with increased 
risk for OSA, such as obese males. 
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